Target validation and drug discovery using genomic and protein–protein interaction technologies

Author： Pillutla Renuka C   Fisher Paul B   Blume Arthur J   Goldstein Neil I  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.6, Iss.4, 2002-08, pp. : 517-531

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protein-Protein Interaction (PPI) Network: Recent Advances in Drug Discovery

By  

Current Drug Metabolism, Vol. 18, Iss. 1, 2017-01 ,pp. : 5-10

Bentham Science Publishers

Access to resources Recommend Favorite

Using Fragment-Based Technologies to Target Protein-Protein Interactions

By  

Current Pharmaceutical Design, Vol. 18, Iss. 30, 2012-10 ,pp. : 4685-4696

Bentham Science Publishers

Access to resources Recommend Favorite

Protein-Protein Interactions in Drug Discovery

By  

Drug Design Reviews - Online, Vol. 2, Iss. 3, 2005-05 ,pp. : 179-207

Bentham Science Publishers

Access to resources Recommend Favorite

RNA Silencing Technologies in Drug Discovery and Target Validation

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 1, 2005-02 ,pp. : 1-18

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot topic: The Protein-Protein Interactions as a Target in Medicinal Chemistry and Drug Discovery (Guest Editor: Gabriela Mustata)]

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 3, 2011-02 ,pp. : 247-247

Bentham Science Publishers

Access to resources Recommend Favorite